© 2020 Recharge Biomedical
Exosomes and TA-65 are not FDA-approved to prevent or treat any illness
Before 2007 when we started using TA-65 with psoriasis patients, we might have thought that was an immune enhancer might have been concerning for autoimmune-type diseases.
In the case of psoriasis and other conditions, immune-enhancing adaptogens don't appear to worsen and may be associated with a benefit.
- Written:
- Author: Edward
- Posted in: News
- Tags: adaptogens, Dr. Ed Park, eczema, podcasts, psoriasis, remicade, skin health, ta-65
Reading Time: < 1 minute
Psoriasis webinar
Psoriasis is more like a normal variant than a disease as I explain in this webinar.
Before 2007 when we started using TA-65 with psoriasis patients, we might have thought that was an immune enhancer might have been concerning for autoimmune-type diseases.
In the case of psoriasis and other conditions, immune-enhancing adaptogens don’t appear to worsen and may be associated with a benefit.
